After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring
- Swedish: 17 events in the last 90 days
- Previous: earlier the same day · King signs collective agreement with Swedish trade unions following call to industrial action last week
What happened
Just days after a capital-markets day left investors wondering what’s next for Novo Nordisk, the Danish drug giant struck a licensing deal worth over $1 billion.
Summary assembled by rule from the sources below